Prevalence and clinical implication of metabolic syndrome in chronic heart failure - Report from MetS-CHF study

Yutaka Miura, Yoshihiro Fukumoto, Nobuyuki Shiba, Toshiro Miura, Kazunori Shimada, Yoshitaka Iwama, Atsutoshi Takagi, Hidenori Matsusaka, Takaki Tsutsumi, Akira Yamada, Shintaro Kinugawa, Masanori Asakura, Shuichi Okamatsu, Hiroyuki Tsutsui, Hiroyuki Daida, Masunori Matsuzaki, Hitonobu Tomoike, Hiroaki Shimokawa

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Metabolic syndrome (MetS) is a pathological condition with a clustering of metabolic components and is a well-known risk and prognostic factor for ischemic heart disease (IHD). However, the prevalence and clinical significance of MetS remain to be fully elucidated in chronic heart failure (CHF), an important clinical syndrome caused by various cardiac abnormalities. Methods and Results: The present nationwide, large-scale clinical study enrolled 3,603 patients with stage C/D CHF from 6 institutes in Japan. First, the prevalence of MetS in CHF patients was demonstrated to be 45% in males and 19% in females, which is more than double compared with the general population in Japan. The CHF patients with MetS were characterized by younger age, higher prevalence of current smoking and drinking, IHD, and hypertensive heart disease, whereas the prevalence of HF with preserved ejection fraction and MetS was higher in elderly female patients. Next, the contribution of the metabolic components (waist circumference, hypertension, glucose intolerance/diabetes mellitus and dyslipidemia) was found to be comparable between the ischemic and the non-ischemic CHF patients. Conclusions: The prevalence of MetS in CHF patients is more than double compared with the general population in Japan and suggest that the metabolic components may have a substantial effect on the development of both ischemic and non-ischemic CHF.

Original languageEnglish
Pages (from-to)2612-2621
Number of pages10
JournalCirculation Journal
Volume74
Issue number12
DOIs
Publication statusPublished - Dec 8 2010
Externally publishedYes

Fingerprint

Heart Failure
Japan
Myocardial Ischemia
Glucose Intolerance
Waist Circumference
Dyslipidemias
Population
Drinking
Cluster Analysis
Heart Diseases
Diabetes Mellitus
Smoking
Hypertension

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Miura, Y., Fukumoto, Y., Shiba, N., Miura, T., Shimada, K., Iwama, Y., ... Shimokawa, H. (2010). Prevalence and clinical implication of metabolic syndrome in chronic heart failure - Report from MetS-CHF study. Circulation Journal, 74(12), 2612-2621. https://doi.org/10.1253/circj.CJ-10-0677

Prevalence and clinical implication of metabolic syndrome in chronic heart failure - Report from MetS-CHF study. / Miura, Yutaka; Fukumoto, Yoshihiro; Shiba, Nobuyuki; Miura, Toshiro; Shimada, Kazunori; Iwama, Yoshitaka; Takagi, Atsutoshi; Matsusaka, Hidenori; Tsutsumi, Takaki; Yamada, Akira; Kinugawa, Shintaro; Asakura, Masanori; Okamatsu, Shuichi; Tsutsui, Hiroyuki; Daida, Hiroyuki; Matsuzaki, Masunori; Tomoike, Hitonobu; Shimokawa, Hiroaki.

In: Circulation Journal, Vol. 74, No. 12, 08.12.2010, p. 2612-2621.

Research output: Contribution to journalArticle

Miura, Y, Fukumoto, Y, Shiba, N, Miura, T, Shimada, K, Iwama, Y, Takagi, A, Matsusaka, H, Tsutsumi, T, Yamada, A, Kinugawa, S, Asakura, M, Okamatsu, S, Tsutsui, H, Daida, H, Matsuzaki, M, Tomoike, H & Shimokawa, H 2010, 'Prevalence and clinical implication of metabolic syndrome in chronic heart failure - Report from MetS-CHF study', Circulation Journal, vol. 74, no. 12, pp. 2612-2621. https://doi.org/10.1253/circj.CJ-10-0677
Miura, Yutaka ; Fukumoto, Yoshihiro ; Shiba, Nobuyuki ; Miura, Toshiro ; Shimada, Kazunori ; Iwama, Yoshitaka ; Takagi, Atsutoshi ; Matsusaka, Hidenori ; Tsutsumi, Takaki ; Yamada, Akira ; Kinugawa, Shintaro ; Asakura, Masanori ; Okamatsu, Shuichi ; Tsutsui, Hiroyuki ; Daida, Hiroyuki ; Matsuzaki, Masunori ; Tomoike, Hitonobu ; Shimokawa, Hiroaki. / Prevalence and clinical implication of metabolic syndrome in chronic heart failure - Report from MetS-CHF study. In: Circulation Journal. 2010 ; Vol. 74, No. 12. pp. 2612-2621.
@article{9ad1a2183bd14d629c71c5f84f6c3819,
title = "Prevalence and clinical implication of metabolic syndrome in chronic heart failure - Report from MetS-CHF study",
abstract = "Background: Metabolic syndrome (MetS) is a pathological condition with a clustering of metabolic components and is a well-known risk and prognostic factor for ischemic heart disease (IHD). However, the prevalence and clinical significance of MetS remain to be fully elucidated in chronic heart failure (CHF), an important clinical syndrome caused by various cardiac abnormalities. Methods and Results: The present nationwide, large-scale clinical study enrolled 3,603 patients with stage C/D CHF from 6 institutes in Japan. First, the prevalence of MetS in CHF patients was demonstrated to be 45{\%} in males and 19{\%} in females, which is more than double compared with the general population in Japan. The CHF patients with MetS were characterized by younger age, higher prevalence of current smoking and drinking, IHD, and hypertensive heart disease, whereas the prevalence of HF with preserved ejection fraction and MetS was higher in elderly female patients. Next, the contribution of the metabolic components (waist circumference, hypertension, glucose intolerance/diabetes mellitus and dyslipidemia) was found to be comparable between the ischemic and the non-ischemic CHF patients. Conclusions: The prevalence of MetS in CHF patients is more than double compared with the general population in Japan and suggest that the metabolic components may have a substantial effect on the development of both ischemic and non-ischemic CHF.",
author = "Yutaka Miura and Yoshihiro Fukumoto and Nobuyuki Shiba and Toshiro Miura and Kazunori Shimada and Yoshitaka Iwama and Atsutoshi Takagi and Hidenori Matsusaka and Takaki Tsutsumi and Akira Yamada and Shintaro Kinugawa and Masanori Asakura and Shuichi Okamatsu and Hiroyuki Tsutsui and Hiroyuki Daida and Masunori Matsuzaki and Hitonobu Tomoike and Hiroaki Shimokawa",
year = "2010",
month = "12",
day = "8",
doi = "10.1253/circj.CJ-10-0677",
language = "English",
volume = "74",
pages = "2612--2621",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "12",

}

TY - JOUR

T1 - Prevalence and clinical implication of metabolic syndrome in chronic heart failure - Report from MetS-CHF study

AU - Miura, Yutaka

AU - Fukumoto, Yoshihiro

AU - Shiba, Nobuyuki

AU - Miura, Toshiro

AU - Shimada, Kazunori

AU - Iwama, Yoshitaka

AU - Takagi, Atsutoshi

AU - Matsusaka, Hidenori

AU - Tsutsumi, Takaki

AU - Yamada, Akira

AU - Kinugawa, Shintaro

AU - Asakura, Masanori

AU - Okamatsu, Shuichi

AU - Tsutsui, Hiroyuki

AU - Daida, Hiroyuki

AU - Matsuzaki, Masunori

AU - Tomoike, Hitonobu

AU - Shimokawa, Hiroaki

PY - 2010/12/8

Y1 - 2010/12/8

N2 - Background: Metabolic syndrome (MetS) is a pathological condition with a clustering of metabolic components and is a well-known risk and prognostic factor for ischemic heart disease (IHD). However, the prevalence and clinical significance of MetS remain to be fully elucidated in chronic heart failure (CHF), an important clinical syndrome caused by various cardiac abnormalities. Methods and Results: The present nationwide, large-scale clinical study enrolled 3,603 patients with stage C/D CHF from 6 institutes in Japan. First, the prevalence of MetS in CHF patients was demonstrated to be 45% in males and 19% in females, which is more than double compared with the general population in Japan. The CHF patients with MetS were characterized by younger age, higher prevalence of current smoking and drinking, IHD, and hypertensive heart disease, whereas the prevalence of HF with preserved ejection fraction and MetS was higher in elderly female patients. Next, the contribution of the metabolic components (waist circumference, hypertension, glucose intolerance/diabetes mellitus and dyslipidemia) was found to be comparable between the ischemic and the non-ischemic CHF patients. Conclusions: The prevalence of MetS in CHF patients is more than double compared with the general population in Japan and suggest that the metabolic components may have a substantial effect on the development of both ischemic and non-ischemic CHF.

AB - Background: Metabolic syndrome (MetS) is a pathological condition with a clustering of metabolic components and is a well-known risk and prognostic factor for ischemic heart disease (IHD). However, the prevalence and clinical significance of MetS remain to be fully elucidated in chronic heart failure (CHF), an important clinical syndrome caused by various cardiac abnormalities. Methods and Results: The present nationwide, large-scale clinical study enrolled 3,603 patients with stage C/D CHF from 6 institutes in Japan. First, the prevalence of MetS in CHF patients was demonstrated to be 45% in males and 19% in females, which is more than double compared with the general population in Japan. The CHF patients with MetS were characterized by younger age, higher prevalence of current smoking and drinking, IHD, and hypertensive heart disease, whereas the prevalence of HF with preserved ejection fraction and MetS was higher in elderly female patients. Next, the contribution of the metabolic components (waist circumference, hypertension, glucose intolerance/diabetes mellitus and dyslipidemia) was found to be comparable between the ischemic and the non-ischemic CHF patients. Conclusions: The prevalence of MetS in CHF patients is more than double compared with the general population in Japan and suggest that the metabolic components may have a substantial effect on the development of both ischemic and non-ischemic CHF.

UR - http://www.scopus.com/inward/record.url?scp=78649698402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649698402&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-10-0677

DO - 10.1253/circj.CJ-10-0677

M3 - Article

C2 - 20953060

AN - SCOPUS:78649698402

VL - 74

SP - 2612

EP - 2621

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 12

ER -